Robitussin Medi-Soothers 5 mg/1
dextromethorphan hydrobromide, menthol · LOZENGE · Haleon US Holdings LLC
Robitussin Medi-Soothers is a lozenge containing dextromethorphan hydrobromide, menthol at 5 mg/1, taken oral. Manufactured by Haleon US Holdings LLC.
Key Facts
- Brand Name
- Robitussin Medi-Soothers
- Generic Name
- dextromethorphan hydrobromide, menthol
- NDC Code (Product)
0031-9306- Manufacturer
- Haleon US Holdings LLC
- Strength
- 5 mg/1
- Dosage Form
- LOZENGE
- Route
- ORAL
- Marketing Status
- Application #
- M012
- Marketing Start
- 06/01/2023
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Robitussin Medi-Soothers used for?
Robitussin Medi-Soothers contains dextromethorphan hydrobromide, menthol. It is a lozenge taken oral. Consult your doctor for specific uses.
Is Robitussin Medi-Soothers a controlled substance?
Robitussin Medi-Soothers is not classified as a controlled substance by the DEA.
What is the generic name for Robitussin Medi-Soothers?
The generic name for Robitussin Medi-Soothers is dextromethorphan hydrobromide, menthol. There are no other listed brand versions of dextromethorphan hydrobromide, menthol.
What is the NDC code for Robitussin Medi-Soothers 5 mg/1?
The NDC (National Drug Code) for Robitussin Medi-Soothers 5 mg/1 is 0031-9306, listed by Haleon US Holdings LLC.
Other Robitussin Medi-Soothers Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)